Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs

BOSTON and ATLANTA, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage phar...

Related Keywords

Georgia ,United States ,Boston ,Massachusetts ,Atlanta ,Alex Lobo ,Miltonh Werner ,Company Contact ,Youtube ,Facebook ,Inhibikase Therapeutics Inc ,Inhibikase Or Company ,European Union ,Sternir Inc ,Exchange Commission ,Nasdaq ,Linkedin ,Abelson Tyrosine Kinases ,Fellow Shareholders ,Inhibikase Therapeutics ,Multiple System Atrophy ,Orphan Drug Designation ,Abelson Tyrosine Kinase ,Ableson Tyrosine ,Private Securities Litigation Reform Act ,